The Efficacity of Hemodiafiltration Versus Hemofiltration for Renal Insufficiency During Intensive Care
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jul 26, 2011
Trial Information
Current as of May 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • According to RIFLE score, patient is stage 'F'
- • The patient must be insured or beneficiary of a health insurance plan
- * The patient meets at least one of the following criteria:
- • metabolic acidosis (pH \< 7.2), excluding keto-acidosis
- • plasma urea \> 25 mmol/l
- • hyper-hydration is not controlled by diuretics
- Exclusion Criteria:
- • Chronic, terminal renal insufficiency with dialysis
- • The patient is under judicial protection, under tutorship or curatorship
- • Suspect hyperkaliemia (Kaliemia \> 6.5 mmol/l with electrocardiographic effects)
- • Intoxications treated via dialysis
- • Pregnant, lactating, parturient women
- • Medical indication for localized citrate anticoagulation
- • dialysis of less than 12 h
- • patient or representative refuses to participate
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nîmes Cedex 09, Gard, France
Patients applied
Trial Officials
Pascal Jeannes, MD
Principal Investigator
Centre Hospitalier Universitaire de Nîmes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials